Home  »  ICIC  »  Speakers since 2005  »  David Martin

David Martin


David E. Martin, PhD, is the founding CEO of M·CAM, Inc., the international leader in intellectual property-based financial risk management. M·CAM has established a global standard in intangible asset-backed finance, innovation finance arbitrage for the public and private sector, technology proliferation and counter-proliferation tracking, and patent quality and commercial validity assessment and management. Dr. Martin is also a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration.

A spokesperson for global intellectual-property accountability and quality reform, Dr. Martin has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States, Europe, and Asia in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions. M·CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.

Dr. Martin has founded several for-profit and not-for-profit companies and organizations and serves on several boards. He was the founding CEO of Mosaic Technologies, Inc., a company that developed and commercialized technologies in advanced computational linguistics, dynamic data

compression and encryption, electrical field transmission, medical diagnostics, and stealth/anechoic.He was a founding member of Japan's Institute for Interface Science and Technology (IIST). He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington, D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the IIST (Japan), the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia).

As a former Assistant Professor at the University of Virginia's School of Medicine, Dr. Martin founded the University's first wholly-owned, for-profit, research and development, and technology-transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques in innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia's Center for Innovative Technology (CIT) on numerous occasions.

Dr. Martin's work as a Fellow of the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible-asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised intellectual property-based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, and the United Arab Emirates.

Dr. Martin has received several honors for his contribution to domestic and international entrepreneurial activities. Highlights include:

  • Fellow of the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia;
  • Board of Advisors, EU-India, Academy for Augmenting Sustainable Technological Inventions, Innovations, and Traditional Knowledge (AASTIIK);
  • Induction as a Guild Member of the Order of King Christian IV of Denmark;
  • Recipient of the Charlottesville Venture Group's Golden Angel Award; and,
  • Recipient of the Virginia Piedmont Technology Council's Spotlight Award.

Dr. Martin has publications in law, medicine, engineering, finance, and education. He maintains active research in the fields of linguistic genomics, fractal financial-risk modeling, and cellular membrane ionic signaling.


Innovation and the Birth of the Fusion Economy: Financial Implications of Intellectual Property (ICIC 2007 - The Meeting)